Search results
Added:
8 months ago
ACC 25 - SMART-CHOICE 3 Trial finds clopidogrel monotherapy to be the optimal anti-thrombotic strategy in high risk patients with contemporary drug-eluting stents.Dr Joo-Yong Hahn (Samsung Medical Center, Seoul, KR) joins us onsite at ACC Conference 2025 to discuss the findings from the SMART-CHOICE 3 study (NCT04418479). The study aims to evaluate the efficacy and safety of clopidogrel…
View more
Added:
1 day ago
Source:
Radcliffe Cardiology
An artificial intelligence (AI) algorithm can identify high-risk coronary plaques on optical coherence tomography (OCT) images and predict adverse outcomes, according to findings from the PECTUS-AI study.¹ The research suggests that AI-assisted analysis of the entire imaged vessel provides superior prognostic value compared to manual analysis of a target lesion alone.Coronary thin-cap…
View more
Added:
1 month ago
TCT 2025 - The randomized VICTORY Study finds OCT-guided PCI involving lesion preparation with the OPN super-high-pressure non-compliant balloon is non-inferior to intravascular lithotropsy.Dr Matthias Bossard (Kantonsspital Lucerne, Lucerne, CH) joins us to discuss findings from the VICTORY Trial, a randomized, multicenter, non-inferiority comparison evaluating intravascular lithotripsy versus…
View more
Added:
3 weeks ago
Added:
1 week ago
Source:
Radcliffe Cardiology
The optimal duration of dual antiplatelet therapy (DAPT) following percutaneous coronary intervention (PCI) remains a subject of clinical debate. A new randomised trial, PARTHENOPE (NCT04135989), suggests that personalising the duration of DAPT based on a clinical risk score reduces the risk of net adverse clinical events compared to a standard 12-month course of treatment.¹The PARTHENOPE trial…
View more
Evolving Strategies in Pulmonary Embolism: From Risk Stratification to Interventional Therapy
Added:
3 days ago
Video Series
Added:
3 months ago
Source:
Radcliffe Cardiology
Adding aspirin to an oral anticoagulant (OAC) regimen results in a higher risk of ischaemic events, all-cause mortality, and major bleeding in patients with chronic coronary syndrome (CCS) at high atherothrombotic risk, according to the results of the AQUATIC trial.¹ The study was stopped early due to an excess of deaths in the aspirin group.The AQUATIC trial was a multicentre, double-blind,…
View more
Added:
6 months ago
Added:
1 year ago
Added:
2 years ago